Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 1.545.163.901.571.23

What is the latest Working Capital/Sales ratio of ORCHID PHARMA ?

The latest Working Capital/Sales ratio of ORCHID PHARMA is 1.54 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.54
Mar20235.16
Mar20223.90
Mar20211.57
Mar20201.23

How is Working Capital/Sales of ORCHID PHARMA Trending?

Years Working Capital/Sales % Change
Mar2024 1.54
-70.16
Mar2023 5.16
32.31
Mar2022 3.9
148.41
Mar2021 1.57
27.64
Mar2020 1.23 -

Other Financial Ratios of ORCHID PHARMA


Compare Working Capital/Sales ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,752.3 Cr 4.2% 2.3% -48.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,219.0 Cr 0.4% 1.7% 2% Stock Analytics
DIVIS LABORATORIES ₹175,227.0 Cr -0.3% -3.8% 35.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,643.0 Cr 3.9% 11.8% 20% Stock Analytics
CIPLA ₹125,541.0 Cr 1.5% 3.8% 2% Stock Analytics
DR REDDYS LABORATORIES ₹106,063.0 Cr -0.5% -0.1% -5.1% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

4.2%

2.3%

-48.7%

SENSEX

-1.2%

-3%

-0.2%


You may also like the below Video Courses